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The objective of this study was to compare the associations of ac-
celerometer-derived total activity counts per day and minutes of
bouted moderate to vigorous physical activity (MVPA) with in-
sulin resistance.
Methods
The  sample  included  2,394  adults  (aged  ≥20  y)  from  the
2003–2006 National Health and Nutrition Examination Survey.
Time spent  in MVPA, measured by using 2 cutpoints  (≥2,020
counts/min [MVPA2,020] and ≥760 counts/min [MVPA760]), was
calculated for  bouts  of  at  least  8 to 10 minutes.  Total  activity
counts per day reflects the total amount of activity across all in-
tensities.  Insulin resistance was measured via the homeostatic
model assessment of insulin resistance (HOMA-IR) and the quant-
itative insulin sensitivity check index (QUICKI). Two nested re-
gression models regressed HOMA-IR and QUICKI, respectively,
on minutes of bouted MVPA and total activity counts per day. We
used an adjusted Wald F statistic to illustrate strength of associ-
ation.
Results
After adjustment for covariates, total activity counts per day was
more strongly associated with both HOMA-IR (adjusted Wald F =
36.83 , P < .001) and QUICKI (adjusted Wald F = 29.44, P < .001)
compared with MVPA2,020 (HOMA-IR, adjusted Wald F = 4.00, P
= .06; QUICKI, adjusted Wald F = 1.08, P = .31).Total activity
counts per day was more strongly associated with both HOMA-IR
(adjusted Wald F = 13.64, P < .001) and QUICKI (adjusted Wald
F = 12.10, P < .001) compared with MVPA760 (HOMA-IR, adjus-
ted Wald F = 1.13, P = .30; QUICKI, adjusted Wald F = 0.97, P =
.33).
Conclusion
Our study indicated that total activity counts per day has stronger
associations with insulin resistance compared with minutes of
bouted MVPA. The most likely explanation is that total activity
counts per day captures data on light physical activity and inter-
mittent MVPA, both of which influence insulin resistance.
Introduction
Insulin resistance is associated with an increased risk for cardi-
ovascular disease (1), diabetes (2), and other metabolic disorders.
An estimated 30% of the US adult population is insulin resistant
(3). Investigating ways to prevent or delay insulin resistance, re-
searchers have focused on the role of physical activity. Studies
have highlighted the importance of both total volume (4) and in-
tensity (5) of physical activity in relation to insulin resistance. One
study (5) found a significant difference in insulin response after 7
days of exercise at 70% of maximal oxygen consumption but no
difference in those exercising at 50% of maximal oxygen con-
sumption. In contrast, another study (4) found lower levels of in-
sulin resistance independent of intensity among people exercising
at 170 minutes per week compared with people exercising 115
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minutes per week. Results of cross-sectional studies also indic-
ated that higher levels of moderate to vigorous physical activity
(MVPA), both bouted (6) and nonbouted (7), were associated with
lower levels of insulin resistance.
Wearable monitors that can assess physical activity on a minute-
by-minute basis (8,9) have improved researchers’ ability to exam-
ine the relationship between physical activity and various chronic
conditions such as insulin resistance (6,7,10). Methods of analyz-
ing accelerometer data allow researchers to classify minutes spent
in  light  physical  activity  (LPA),  moderate  physical  activity
(MPA), and vigorous physical activity (VPA); several cutpoints
have been established to measure time spent in these intensities
(11). However, recent studies show the limitations of these meth-
ods in accurately quantifying time (8,12); for example, these meth-
ods miss upwards of 50% of the time spent in MVPA. Because of
these limitations, a new metric for quantifying accelerometer-de-
rived data is being used: total activity counts per day (TAC/d).
This metric incorporates data on physical activity across all intens-
ities, frequencies, and durations (9).
Only 2 recent studies show that accelerometer-derived measures of
TAC/d are associated with insulin resistance (13,14). A study pub-
lished in 2014 (13) showed that TAC/d was significantly associ-
ated with measures of insulin sensitivity derived from the homeo-
static model assessment of insulin resistance (HOMA-IR). Fur-
thermore, the use of TAC/d eliminated the association between
sedentary time and HOMA-IR. A study published in 2015 of a
population-based  sample  (14)  found  that  TAC/d  was  more
strongly associated with multiple insulin resistance–related risk
factors — fasting blood glucose, fasting insulin, and C-peptide —
than was bouted MVPA.
Although both bouted and nonbouted MVPA are associated with
insulin resistance, the aforementioned studies indicate that TAC/d
should  be  considered when assessing the  association between
physical activity and insulin resistance. Furthermore, it is neces-
sary measure the total volume of activity, because subsets of total
volume, such as MVPA, may not fully illustrate the relationship
between physical activity and insulin resistance (9,13). To date, no
studies have investigated the associations between objectively
measured physical activity and insulin resistance by measuring
both MVPA and total volume of physical activity. The objective
of this study was to determine which measure — MVPA or TAC/d
—is more strongly associated with 2 markers of insulin resistance
commonly used in epidemiological research — HOMA-IR and the
quantitative insulin sensitivity check index (QUICKI) — in a rep-
resentative sample of US adults.  The results of this study will
provide further insight into the relationship of TAC/d and bouted
MVPA with insulin resistance and the use of these 2 measures in
epidemiologic research.
Methods
This study used data from the 2003–2006 National Health and Nu-
trition Examination Survey (NHANES), a cross-sectional survey
conducted by the National Center for Health Statistics that uses a
complex, multistage sampling design to obtain a representative
sample  of  the  US population (15).  NHANES was designed to
provide national estimates of the health and nutritional status of
noninstitutionalized US civilians aged 2 months or older. Our ana-
lytic sample (n = 2,394) met the following conditions: 1) they
were adult men and women aged 20 years or older; 2) they atten-
ded  a  morning  mobile  examination  center  (MEC)  after  an
overnight fast of 8 to 9 hours; 3) if female, they were not pregnant
or lactating; 4) they had complete data on all the variables of in-
terest; and 5) they had at least 4 days of accelerometer data with
10 or more hours per day of wear time.
Accelerometer-derived physical activity
Eligible participants were those who participated in the MEC com-
ponent of NHANES, were ambulatory, and agreed to participate.
Eligible participants were given an ActiGraph model 7164 acceler-
ometer and were instructed to wear the device on the right hip for
7 consecutive days (16). Because the ActiGraph is not waterproof,
participants were instructed to remove the device during activities
in water, such as bathing or swimming (16). Participants were in-
structed to remove the device also while sleeping.
Accelerometer data were recorded in 1-minute epochs. Nonwear
time  was  defined  as  60  minutes  or  more  of  no  accelerometer
counts, with 2 minutes or fewer of limited movement between
zero and 100 counts. Wear time was calculated by subtracting the
total nonwear time from 24 hours. Participants who had at least 4
days with 10 hours or more hours of valid wear time per day were
included in the analysis (16). Several cutpoints exist to denote
minutes of MVPA (11). For our study, we used 2 cutpoints for
bouted MVPA. One cutpoint (MVPA2,020) was defined as minutes
consisting of 2,020 or more activity counts that were accumulated
in bouts of at least 10 minutes (with 1–2 minutes allowed below
the threshold) (17). A second cutpoint (MVPA760) was defined as
minutes consisting of 760 or more activity counts that were accu-
mulated in bouts of at least 10 minutes (with 1–2 minutes allowed
below the threshold) (18). These cutpoints are consistently ap-
plied to NHANES data (11). TAC/d was created by summing up
the total activity counts and dividing by the number of valid wear
days (14).
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Insulin resistance
Insulin resistance measures were HOMA-IR (19) and QUICKI
(20), both of which are used in NHANES data analyses (21,22).
The HOMA-IR equation was created as a surrogate marker of in-
sulin resistance based on the negative-feedback loop between the
liver and β cells (19). QUICKI is a measure of insulin sensitivity,
with lower levels reflecting a greater degree of insulin resistance.
The QUICKI method is an equation derived from fasting insulin
and glucose levels (similar to HOMA-IR) and is based on the lin-
ear relationship of these variables with the gold-standard hyper-
insulinemic–euglycemic clamp technique (20). Before calculating
HOMA-IR and QUICKI, we corrected for differences between the
2005–2006 NHANES cycle and the 2003–2004 NHANES cycle in
measuring insulin and glucose values (23). The assays used to
measure insulin and glucose changed between 2003–2004 and
2005–2006. NHANES provides an equation to account for those
differences, and it was applied before analyzing the data. Data on
HOMA-IR were logarithmically transformed, because they were
nonnormally distributed.
Covariates
We included sociodemographic variables, wear-time variables,
and markers of health and behavior as covariates.  Sociodemo-
graphic variables were age (continuous variable in years),  sex
(male and female), race/ethnicity (non-Hispanic white, non-His-
panic black, Mexican American, and other), and education (<high
school graduate, high school graduate/general educational devel-
opment [GED], some college, and college graduate). Health and
behavior  variables  included  smoking  status  (current  smoker,
former smoker [those reporting quitting within the previous 6
months], and nonsmoker), measured waist circumference, hyper-
tension, and diabetes. Waist circumference was treated as a con-
tinuous variable. Participants were classified as having hyperten-
sion if they had a measured systolic blood pressure of 140 mm Hg
or more or a diastolic blood pressure of 90 mm Hg or more (24),
self-reported physician-diagnosed hypertension, or were currently
taking medication for hypertension. Diabetes status was categor-
ized into 3 levels: no diabetes, prediabetes, and diabetes. Those
classified as having diabetes met 1 of the following conditions:
answered yes to the question “Has a doctor or health-professional
ever told you that you have diabetes?,” were currently taking med-
ication for diabetes, or had a fasting blood glucose 126 mg/dL or
more  (25).  Prediabetes  was  defined  as  having  physician-dia-
gnosed prediabetes or a fasting glucose ranging from 100 to 125
mg/dL (25). Participants were classified as not having diabetes if
they answered no to the question “Has a doctor or health-profes-
sional ever told you that you have diabetes?” and having a fasting
glucose of less than 100 mg/dL (25).
All analyses were conducted using SAS 9.4 (SAS Institute, Inc).
We used the proc surveyreg procedure, which accounts for the
complex sampling design and survey nonresponse inherent  to
NHANES (15). Fasting subsample weights were used, thus ensur-
ing the proper subsample for all analyses. Weighted prevalence es-
timates were generated for all categorical variables. The weighted
mean, standard error, and range were generated for all continuous
variables.
Age-adjusted linear regressions were performed; these regressed
TAC/d and MVPA separately on each measure of insulin resist-
ance.  Two nested linear regression models were created.  Both
physical activity metrics were simultaneously entered into the re-
gression models to examine the difference in the magnitude of the
association between each physical activity metric and insulin res-
istance. Model 1 included all covariates except waist circumfer-
ence. Model 2 included all covariates from model 1 plus waist cir-
cumference. The Wald F statistic was used to indicate the strength
of association for both physical activity metrics. A larger Wald F
indicates a stronger association with the dependent variable (26).
For the regression models using MVPA2,020 and TAC/d, multicol-
linearity was checked and not found to violate the variance infla-
tion factor threshold (<5) (27,28). In the regression models using
MVPA760  and TAC/d the variance inflation factor statistic was
5.7, violating the threshold set for the analysis. A variance infla-
tion factor of less than 5 is a conservative statistic, and other stud-
ies have used a value of less than 10 (29).
Results
The mean age of our study sample was 48.3 years; 51.4% were
women, 73.5% were non-Hispanic white, 32.1% had some col-
lege, 51.4% were nonsmokers, 26.9% had hypertension, and 6.5%
had diabetes (Table 1). The age-adjusted linear regressions (Table
2) showed that MVPA2,020 was significantly associated with both
HOMA-IR (β = −0.01, P < .001) and QUICKI (β = 0.0003, P <
.001).  MVPA760  was  also  significantly  associated  with  both
HOMA-IR (β =  −0.003, P < .001) and QUICKI (β = 0.00001, P <
.001). TAC/d was also significantly associated with both HOMA-
IR (β = −0.000002, P < .001) and QUICKI (β = 0.00000004, P <
.001).
The nested regression analyses that  used both MVPA2,020  and
TAC/d in the same regression model and adjusted for covariates
(excluding waist circumference) showed that TAC/d was more
strongly associated with HOMA-IR (adjusted Wald F = 58.97, P <
.001) and QUICKI (adjusted Wald F = 46.71, P < .001) than was
MVPA2,020  (HOMA-IR,  adjusted  Wald  F  =  0.62,  P  =  .44;
QUICKI, adjusted Wald F = 1.10, P = .30) (Table 3). After adjust-
ment for waist circumference, TAC/d remained a stronger predict-
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or of HOMA-IR (adjusted Wald F = 36.83, P < .001) and QUICKI
(adjusted Wald F = 29.44, P < .001) compared with MVPA2,020
(HOMA-IR, adjusted Wald F = 4.00, P = .06; QUICKI, adjusted
Wald F = 1.08, P = .31).
The nested regression analyses that used MVPA760 and TAC/d and
adjusted for covariates (excluding waist circumference) found that
TAC/d was more strongly associated with HOMA-IR (adjusted
Wald F = 31.59, P < .001) and QUICKI (adjusted Wald F = 28.00,
P < .001) than was MVPA760 (HOMA-IR, adjusted Wald F = 2.18,
P = .15; QUICKI, adjusted Wald F = 1.93, P = .17) (Table 3).
After  adjustment  for  waist  circumference,  TAC/d  remained  a
stronger predictor of HOMA-IR (adjusted Wald F = 13.64, P <
.001) and QUICKI (adjusted Wald F = 12.10, P < .001) compared
with  MVPA760  (HOMA-IR,  adjusted  Wald  F  =  1.13,  P  =  .30;
QUICKI, adjusted Wald F = 0.97, P = .33).
Discussion
The results  of  this  study provide  insight  into  the  associations
between objectively measured physical activity and insulin resist-
ance. In separate models, both MVPA and TAC/d were signific-
antly associated with insulin resistance. However, the combined
models showed that TAC/d was more strongly associated with in-
sulin resistance than was MVPA. Moreover, regardless of the cut-
points used, bouted minutes of MVPA were not significantly asso-
ciated with insulin resistance in the fully adjusted models.
Our results, which used surrogate measures of insulin resistance,
extend the results reported by investigators (14) who found that
TAC/d, compared with bouted MVPA, was more strongly associ-
ated with insulin resistance–related cardiometabolic risk factors
(ie, fasting glucose, fasting insulin, and C-peptide). Using data
from the 2003–2006 NHANES, another study (13) found signific-
ant associations between TAC/d and HOMA-derived insulin sens-
itivity or β cell function, independent of inactive time. These res-
ults, as well as the results of our study, indicate that TAC/d is im-
portant to consider, independent of MVPA, when examining phys-
ical activity and insulin resistance.
Two possible explanations exist for why TAC/d is more strongly
associated with insulin resistance compared with bouted MVPA.
First, TAC/d is not limited by having to classify each minute ac-
cording to categorical cutpoints that define sedentary time, LPA,
MPA, or VPA; instead, activity counts per minute vary along a
continuous scale (9,12). Second, TAC/d incorporates the intensity,
frequency, and duration of activity, while bouted MVPA repres-
ents only a small subset of the overall volume of physical activity.
Several studies highlight the independent contribution of LPA (30)
and nonbouted MVPA (7,10) in improving insulin resistance pro-
files. The use of TAC/d accounts for the activity attributable to
these other physical activity subcategories, thus strengthening the
relationship between physical activity and insulin resistance. TAC/
d is more strongly related to cardiometabolic risk than MVPA
(14), and our study extends this finding to insulin resistance.
A major strength of this study is the external validity resulting
from the use of a large, nationally representative sample. Another
strength is the use of validated indices of insulin resistance that are
highly correlated with the gold standard euglycemic–hyperinsu-
linemic clamp technique (19,20). This study also has several limit-
ations. First is the use of bouted MVPA minutes using the 2,020
counts-per-minute cutpoint, which can underestimate time spent in
MVPA (12).  However,  these cutpoints  have consistently been
used in NHANES analyses (11). Second, although the 760 counts-
per-minute cutpoint captures more MVPA, it can also overestim-
ate it (12). Third, physical activity may be underestimated by ac-
celerometry because accelerometers cannot capture data on non-
ambulatory movements such as swimming and resistance training.
Fourth, the counts used in this study were specific to the features
of the ActiGraph accelerometer. Thus, these counts cannot be ap-
plied to other devices. Fifth, the metric TAC/d has no intuitive
meaning (9): although it provides insight into the total volume of
physical activity, it  does not have the same kind of immediate
meaning as the number of minutes, for example. However, popu-
lation-referenced TAC/d percentiles standardized by age and sex
were published in 2015 (31); these percentiles were used to char-
acterize differences in physical activity levels across population
subgroups in New York City (32). In the future, criterion-refer-
enced standards for TAC/d may further our understanding of the
relationship between physical activity and chronic disease.
In our study of a nationally representative sample of US adults,
TAC/d, an index of total activity volume, was more strongly asso-
ciated with measures of insulin resistance and insulin sensitivity
compared with minutes of bouted MVPA using the cutpoints of
2,020 counts per minute and 760 counts per minute. We speculate
that the stronger association resulted from the ability of TAC/d to
capture counts associated with LPA and nonbouted MVPA, which
are both independently associated with insulin resistance (7,10).
Future analyses should examine total MVPA defined by the cut-
points used in our study and other common cutpoints to further un-
derstand the relationship between components of physical activity
and insulin resistance. Finally, our study indicates that it is import-
ant to consider physical activity across the entire intensity spec-
trum when investigating physical activity and insulin resistance.
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Tables
Table 1. Sociodemographic, Health, and Physical Activity Characteristics of the Study Samplea (n = 2,394), NHANES 2003–2006
Covariate Valueb





Non-Hispanic white 1,292 (73.5)
Non-Hispanic black 443 (9.7)
Mexican American 485 (7.6)
Other 174 (9.1)
Education
<High school graduate 601 (15.3)
High school graduate/general educational development (GED) 603 (25.8)
Some college 686 (32.1)
College graduate 504 (26.8)
Smoking status
Nonsmoker 1,219 (51.4)
Former smoker (quit within the previous 6 mo) 712 (27.2)
Smoker 463 (21.4)









Total activity counts per day 268,912 (4,247)
Abbreviations: MVPA, moderate to vigorous physical activity; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a The analytic sample (n = 2,394) met the following conditions: 1) they were adult men and women aged 20 years or older; 2) they attended a morning mobile ex-
amination center (MEC) after an overnight fast of 8 to 9 hours; 3) if they were female, were not pregnant or lactating; 4) they had complete data on all the vari-
ables of interest; and 5) they had at least 4 days of accelerometer data with 10 or more hours per day of wear time.
b All values are number (weighted percentage) unless otherwise indicated.
c Sample size was 2,394.
d Defined as systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg, self-reported physician-diagnosed hypertension, or taking medication.
e Physician-diagnosed prediabetes or a fasting blood glucose range of 100–125 mg/dL.
f Physician-diagnosed, currently taking medication for diabetes, or having a fasting blood glucose ≥126 mg/dL.
g Data for each of these continuous variables were available for all 2,394 participants.
h MVPA was measured in bouted minutes of activity.
i HOMA-IR: (fasting insulin [uU/mL] × fasting glucose [mmol/L])/22.5.
j QUICKI: 1/(log fasting glucose [mg/dL] + log fasting insulin [uU/mL]).
(continued on next page)
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(continued)
Table 1. Sociodemographic, Health, and Physical Activity Characteristics of the Study Samplea (n = 2,394), NHANES 2003–2006
Covariate Valueb
MVPA ≥2,020 counts/minh, mean (SE), min 7.0 (0.4)
MVPA ≥760 counts/minh, mean (SE), min 15.2 (0.1)
Insulin resistance
Homeostatic model assessment of insulin resistance (HOMA-IR)i 2.8 (0.7)
Quantitative insulin sensitivity check index (QUICKI)j 0.15 (0.0006)
Abbreviations: MVPA, moderate to vigorous physical activity; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a The analytic sample (n = 2,394) met the following conditions: 1) they were adult men and women aged 20 years or older; 2) they attended a morning mobile ex-
amination center (MEC) after an overnight fast of 8 to 9 hours; 3) if they were female, were not pregnant or lactating; 4) they had complete data on all the vari-
ables of interest; and 5) they had at least 4 days of accelerometer data with 10 or more hours per day of wear time.
b All values are number (weighted percentage) unless otherwise indicated.
c Sample size was 2,394.
d Defined as systolic blood pressure ≥140 mm Hg or a diastolic blood pressure ≥90 mm Hg, self-reported physician-diagnosed hypertension, or taking medication.
e Physician-diagnosed prediabetes or a fasting blood glucose range of 100–125 mg/dL.
f Physician-diagnosed, currently taking medication for diabetes, or having a fasting blood glucose ≥126 mg/dL.
g Data for each of these continuous variables were available for all 2,394 participants.
h MVPA was measured in bouted minutes of activity.
i HOMA-IR: (fasting insulin [uU/mL] × fasting glucose [mmol/L])/22.5.
j QUICKI: 1/(log fasting glucose [mg/dL] + log fasting insulin [uU/mL]).
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Table 2. Age-Adjusted Linear Regression Models: Associations Between Accelerometer-Derived MVPA With Measurements of Insulin Resistance and Total Activity
Counts per Day With Measurements of Insulin Resistance, NHANES 2003–2006
Metric
Homeostatic Model Assessment of Insulin Resistance
(HOMA-IR) Quantitative Insulin Sensitivity Check Index (QUICKI)
β (SE) Adjusted Wald F β (SE) Adjusted Wald F
MVPA ≥2,020 counts/min −0.01 (0.002) 61.56a 0.0003 (0.004) 43.51a
MVPA ≥760 counts/min −0.003 (0.004) 52.89a 0.00001 (0.00001) 43.77a
Total activity counts/d −0.000002 (0.000000002) 69.84a 0.00000004 (0.00000001) 57.38a
Abbreviations: MVPA, moderate to vigorous physical activity; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a P < .001.
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Table 3. Multiple Nested Linear Regression: Associations Between Accelerometer-Derived MVPA and Total Activity Counts per Day With Measurements of Insulin
Resistance, NHANES 2003–2006
Measurement
Model 1a Model 2b
β (SE) Adjusted Wald F β (SE) Adjusted Wald F
Homeostatic model assessment of insulin resistance (HOMA-IR)
MVPA ≥2,020 counts/min −0.002 (0.001) 0.62 0.002 (0.001) 4.00
Total activity counts/d −0.000001 (0.0000002) 58.97c −0.000001 (0.0000001) 36.83c
Quantitative insulin sensitivity check index (QUICKI)
MVPA ≥2,020 counts/min 0.00004 (0.00004) 1.10 −0.00004 (0.00004) 1.08
Total activity counts/d 0.00000001 (0.00000001) 46.71c 0.00000002 (0.00000004) 29.44c
Homeostatic model assessment of insulin resistance (HOMA-IR)
MVPA ≥760 counts/min 0.001 (0.001) 2.18 0.001 (0.001) 1.13
Total activity counts/d −0.000002 (0.0000003) 31.59c −0.000001 (0.0000002) 13.64c
Quantitative insulin sensitivity check index (QUICKI)
MVPA ≥760 counts/min −0.00003 (0.00001) 1.93 −0.00002 (0.00002) 0.97
Total activity counts/d 0.0000001 (0.00000001) 28.00c 0.00000003 (0.00000001) 12.10c
Abbreviations: MVPA, moderate to vigorous physical activity; NHANES, National Health and Nutrition Examination Survey; SE, standard error.
a Adjusted for age, sex, race/ethnicity, education, smoking status, diabetes, hypertension, wear time, MVPA, and total activity counts per day.
b All model 1 covariates plus measured waist circumference.
c P < .001.
PREVENTING CHRONIC DISEASE VOLUME 13, E146
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY     OCTOBER 2016
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
10       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2016/16_0159.htm
